Delix Presents Full Results from Phase 1 Trial of DLX-001 at ACNP Annual Meeting [Yahoo! Finance]
FTI Consulting, Inc. (FCN)
Last fti consulting, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
ir.fticonsulting.com
Company Research
Source: Yahoo! Finance
Phase 1 Findings in Healthy Volunteers Support Continued Evaluation of DLX-001 in Recently Initiated Phase 1b Study in Patients with Major Depressive Disorder DLX-159 Nominated as Third Developmental Candidate, Broadening the Company's Portfolio of Novel Neuroplastogens BEDFORD, Mass., December 12, 2024 BUSINESS WIRE Delix Therapeutics , a clinical-stage neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological disorders, today announced full results from the Phase 1 trial evaluating DLX-001, a novel neuroplastogen, in healthy volunteers, which were presented at the 2024 American College of Neuropsychopharmacology (ACNP) Annual Meeting in Phoenix, Arizona. Preclinical data on DLX-159, a next-generation neuroplastogen, were also presented at the meeting. "DLX-001 has continued to demonstrate a favorable safety and tolerability profile, with no evidence of psychotomimetic, hallucinatory, or dissociative effects," said Aaron Koen
Show less
Read more
Impact Snapshot
Event Time:
FCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FCN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FCN alerts
High impacting FTI Consulting, Inc. news events
Weekly update
A roundup of the hottest topics
FCN
News
- FTI Consulting Survey Identifies Renewed Optimism as Healthcare & Life Sciences Sector Embarks on 2025 [Yahoo! Finance]Yahoo! Finance
- FTI Consulting Survey Identifies Renewed Optimism as Healthcare & Life Sciences Sector Embarks on 2025GlobeNewswire
- Change in the Composition of the Exclusive Networks SA Board of Directors [Yahoo! Finance]Yahoo! Finance
- World's Worst Performing Currency Hurts Dollar Borrowers in Brazil [Yahoo! Finance Canada]Yahoo! Finance Canada
- World's Worst Performing Currency Hurts Dollar Borrowers in Brazil [Yahoo! Finance]Yahoo! Finance
FCN
Earnings
- 10/24/24 - Miss
FCN
Sec Filings
- 12/3/24 - Form 4
- 11/7/24 - Form SCHEDULE
- 10/28/24 - Form 8-K
- FCN's page on the SEC website